2,343
Views
19
CrossRef citations to date
0
Altmetric
Clinical Study

Non-traumatic lower limb amputation in patients with end-stage renal failure on dialysis: an Australian perspective

, , , , , & show all
Pages 1036-1043 | Received 01 Jan 2016, Accepted 12 May 2016, Published online: 08 Jun 2016

References

  • Lazzarini PA, Gurr JM, Rogers JR, Schox A, Bergin SM. Diabetes foot disease: The Cinderella of Australian diabetes management? J Foot Ankle Res. 2012;5:24.
  • Bruhn-Olszewska B, Korzon-Burakowska A, Gabig-Ciminska M, Olszewski P, Wegrzyn A, Jakobkiewicz-Banecka J. Molecular factors involved in the development of diabetic foot syndrome. Acta Biochim Pol. 2012;59:507–513.
  • Stiegler H. Diabetic foot syndrome. Herz. 2004;29:104–115.
  • Gregg EW, Gu Q, Williams D, et al. Prevalence of lower extremity diseases associated with normal glucose levels, impaired fasting glucose, and diabetes among U.S. adults aged 40 or older. Diabetes Res Clin Pract. 2007;77:485–488.
  • Ostchega Y, Paulose-Ram R, Dillon CF, Gu Q, Hughes JP. Prevalence of peripheral arterial disease and risk factors in persons aged 60 and older: Data from the National Health and Nutrition Examination Survey 1999–2004. J Am Geriatr Soc. 2007;55:583–589.
  • Jaar BG, Plantinga LC, Astor BC, et al. Novel and traditional cardiovascular risk factors for peripheral arterial disease in incident-dialysis patients. Adv Chronic Kidney Dis. 2007;14:304–313.
  • Rajagopalan S, Dellegrottaglie S, Furniss AL, et al. Peripheral arterial disease in patients with end-stage renal disease: Observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Circulation. 2006;114:1914–1922.
  • Al Wakeel JS, Mitwalli AH, Al Mohaya S, et al. Morbidity and mortality in ESRD patients on dialysis. Saudi J Kidney Dis Transplant. 2002;13:473–477.
  • Luke RG. Chronic renal failure-a vasculopathic state. N Engl J Med. 1998;339:841–843.
  • Jaar BG, Astor BC, Berns JS, Powe NR. Predictors of amputation and survival following lower extremity revascularization in hemodialysis patients. Kidney Int. 2004;65:613–620.
  • Margolis DJ, Hofstad O, Feldman HI. Association between renal failure and foot ulcer or lower-extremity amputation in patients with diabetes. Diabetes Care. 2008;31:1331–1336.
  • Ndip A, Rutter MK, Vileikyte L, et al. Dialysis treatment is an independent risk factor for foot ulceration in patients with diabetes and stage 4 or 5 chronic kidney disease. Diabetes Care. 2010;33:1811–1816.
  • O'Hare AM, Bacchetti P, Segal M, Hsu CY, Johansen KL, Dialysis M. Mortality Study W: Factors associated with future amputation among patients undergoing hemodialysis: Results from the Dialysis Morbidity and Mortality Study Waves 3 and 4. Am J Kidney Dis. 2003;41:162–170.
  • O'Hare AM, Glidden DV, Fox CS, Hsu CY. High prevalence of peripheral arterial disease in persons with renal insufficiency: Results from the National Health and Nutrition Examination Survey 1999–2000. Circulation. 2004;109:320–323.
  • Combe C, Albert JM, Bragg-Gresham JL, et al. The burden of amputation among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2009;54:680–692.
  • Ishii H, Kumada Y, Takahashi H, et al. Impact of diabetes and glycaemic control on peripheral artery disease in Japanese patients with end-stage renal disease: Long-term follow-up study from the beginning of haemodialysis. Diabetologia. 2012;55:1304–1309.
  • Locking-Cusolito H, Harwood L, Wilson B, et al. Prevalence of risk factors predisposing to foot problems in patients on hemodialysis. Nephrol Nurs J. 2005;32:373–384.
  • Maple-Brown LJ, Cunningham J, Zinman B, et al. Cardiovascular disease risk profile and microvascular complications of diabetes: Comparison of Indigenous cohorts with diabetes in Australia and Canada. Cardiovasc Diabetol. 2012;11:30.
  • Malabu UH, Manickam V, Kan G, Doherty SL, Sangla KS. Calcific uremic arteriolopathy on multimodal combination therapy: Still unmet goal. Int J Nephrol. 2012;2012:390768.
  • Norman PE, Schoen DE, Gurr JM, Kolybaba ML. High rates of amputation among Indigenous people in Western Australia. Med J Aust. 2010;192:421.
  • Plantinga LC, Fink NE, Coresh J, et al. Peripheral vascular disease-related procedures in dialysis patients: Predictors and prognosis. Clin J Am Soc Nephrol. 2009;4:1637–1645.
  • Reddy NC, Korbet SM, Wozniak JA, Floramo SL, Lewis EJ. Staff-assisted nursing home hemodialysis: Patient characteristics and outcomes. Nephrol Dialysis Transplant. 2007;22:1399–1406.
  • 2011 Census QuickStats. Available at: http://www.censusdata.abs.gov.au/census_services/getproduct/census/2011/quickstat/LGA37010.
  • Speckman RA, Frankenfield DL, Roman SH, et al. Diabetes is the strongest risk factor for lower-extremity amputation in new hemodialysis patients. Diabetes Care. 2004;27:2198–2203.
  • Boulton AJ, Kubrusly DB, Bowker JH, et al. Impaired vibratory perception and diabetic foot ulceration. Diabetic Med. 1986;3:335–337.
  • Nelson RG, Gohdes DM, Everhart JE, et al. Lower-extremity amputations in NIDDM. 12-yr follow-up study in Pima Indians. Diabetes Care. 1988;11:8–16.
  • Ndip A, Lavery LA, Lafontaine J, et al. High levels of foot ulceration and amputation risk in a multiracial cohort of diabetic patients on dialysis therapy. Diabetes Care. 2010;33:878–880.
  • Jenkins C, Myers P, Heidari K, Kelechi TJ, Buckner-Brown J. Efforts to decrease diabetes-related amputations in African Americans by the Racial and Ethnic Approaches to Community Health Charleston and Georgetown Diabetes Coalition. Fam Commun Health. 2011;34:S63–S78.
  • Bruce SG, Young TK. Prevalence and risk factors for neuropathy in a Canadian First Nation community. Diabetes Care. 2008;31:1837–1841.
  • Meatherall BL, Garrett MR, Kaufert J, et al. Disability and quality of life in Canadian aboriginal and non-aboriginal diabetic lower-extremity amputees. Arch Phys Med Rehabil. 2005;86:1594–1602.
  • Helming L, Bose J, Ehrchen J, et al. 1alpha,25-Dihydroxyvitamin D3 is a potent suppressor of interferon gamma-mediated macrophage activation. Blood. 2005;106:4351–4358.
  • van Etten E, Decallonne B, Bouillon R, Mathieu C. NOD bone marrow-derived dendritic cells are modulated by analogs of 1,25-dihydroxyvitamin D3. J Steroid Biochem Mol Biol. 2004;89-90:457–459.
  • van Etten E, Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: Basic concepts. J Steroid Biochem Mol Biol. 2005;97:93–101.
  • Chua GT, Chan YC, Cheng SW. Vitamin D status and peripheral arterial disease: Evidence so far. Vasc Health Risk Manage. 2011;7:671–675.
  • Gaddipati VC, Bailey BA, Kuriacose R, Copeland RJ, Manning T, Peiris AN. The relationship of vitamin D status to cardiovascular risk factors and amputation risk in veterans with peripheral arterial disease. J Am Med Direct Assoc. 2011;12:58–61.
  • Al-Ahmad A, Rand WM, Manjunath G, et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol. 2001;38:955–962.
  • Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: Insights from a cohort of 12 065 patients with new-onset heart failure. Circulation. 2003;107:223–225.
  • Anand I, McMurray JJ, Whitmore J, et al. Anemia and its relationship to clinical outcome in heart failure. Circulation. 2004;110:149–154.
  • Desormais I, Aboyans V, Bura A, et al. Anemia, an independent predictive factor for amputation and mortality in patients hospitalized for peripheral artery disease. Eur J Vasc Endovasc Surg. 2014;48:202–207.
  • Steel DM, Whitehead AS. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today. 1994;15:81–88.
  • Don BR, Kaysen G. Serum albumin: Relationship to inflammation and nutrition. Semin Dial. 2004;17:432–437.
  • Stechmiller JK. Understanding the role of nutrition and wound healing. Nutr Clin Pract. 2010;25:61–68.
  • Lagrand WK, Visser CA, Hermens WT, et al. C-reactive protein as a cardiovascular risk factor: More than an epiphenomenon? Circulation. 1999;100:96–102.
  • Bild DE, Selby JV, Sinnock P, Browner WS, Braveman P, Showstack JA. Lower-extremity amputation in people with diabetes. Epidemiology and prevention. Diabetes Care. 1989;12:24–31.
  • Apelqvist J, Bakker K, van Houtum WH, Nabuurs-Franssen MH, Schaper NC. International consensus and practical guidelines on the management and the prevention of the diabetic foot. International Working Group on the Diabetic Foot. Diabetes/Metabol Res Rev. 2000;16:S84–S92.
  • Boulton AJ, Armstrong DG, Albert SF, et al. Comprehensive foot examination and risk assessment. A report of the Task Force of the Foot Care Interest Group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Phys Ther. 2008;88:1436–1443.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.